* USDA * Certified Organic

Other Health

Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis

Posted on July 22, 2022

Cannabinoid receptor [CB] activation can attenuate inflammatory bowel disease [IBD] in experimental models and human cohorts. However, the roles of the microbiome, metabolome, and the respective contributions of haematopoietic and non-haematopoietic cells in the anti-colitic effects of cannabinoids have yet to be determined.

QUICK LINKS

REACH OUT TO US

CALL US: 317.973.5097
EMAIL: your.care.team@getbrainbody.com

Disclaimer: This product is not for use by or sale to persons under the age of 21. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. A Doctor’s advice should be sought before using this and any supplemental dietary product. All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse this product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. By using this site, you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void Where Prohibited by Law.